327 related articles for article (PubMed ID: 25712213)
1. Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.
Lourenco S; Teixeira VH; Kalber T; Jose RJ; Floto RA; Janes SM
J Immunol; 2015 Apr; 194(7):3463-74. PubMed ID: 25712213
[TBL] [Abstract][Full Text] [Related]
2. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
Klasen C; Ohl K; Sternkopf M; Shachar I; Schmitz C; Heussen N; Hobeika E; Levit-Zerdoun E; Tenbrock K; Reth M; Bernhagen J; El Bounkari O
J Immunol; 2014 Jun; 192(11):5273-84. PubMed ID: 24760155
[TBL] [Abstract][Full Text] [Related]
3. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74.
Lue H; Dewor M; Leng L; Bucala R; Bernhagen J
Cell Signal; 2011 Jan; 23(1):135-44. PubMed ID: 20807568
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer.
Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM
Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658
[TBL] [Abstract][Full Text] [Related]
5. Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.
Zheng Y; Wang Q; Li T; Qian J; Lu Y; Li Y; Bi E; Reu F; Qin Y; Drazba J; Hsi E; Yang J; Cai Z; Yi Q
J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27381622
[TBL] [Abstract][Full Text] [Related]
6. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC
Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961
[TBL] [Abstract][Full Text] [Related]
7. Intravesical CD74 and CXCR4, macrophage migration inhibitory factor (MIF) receptors, mediate bladder pain.
Ye S; Ma F; Mahmood DFD; Meyer-Siegler KL; Menard RE; Hunt DE; Leng L; Bucala R; Vera PL
PLoS One; 2021; 16(8):e0255975. PubMed ID: 34424927
[TBL] [Abstract][Full Text] [Related]
8. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
[TBL] [Abstract][Full Text] [Related]
9. Cross-kingdom mimicry of the receptor signaling and leukocyte recruitment activity of a human cytokine by its plant orthologs.
Sinitski D; Gruner K; Brandhofer M; Kontos C; Winkler P; Reinstädler A; Bourilhon P; Xiao Z; Cool R; Kapurniotu A; Dekker FJ; Panstruga R; Bernhagen J
J Biol Chem; 2020 Jan; 295(3):850-867. PubMed ID: 31811089
[TBL] [Abstract][Full Text] [Related]
10. Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF.
Schwartz V; Krüttgen A; Weis J; Weber C; Ostendorf T; Lue H; Bernhagen J
Eur J Cell Biol; 2012; 91(6-7):435-49. PubMed ID: 22014447
[TBL] [Abstract][Full Text] [Related]
11. A functional heteromeric MIF receptor formed by CD74 and CXCR4.
Schwartz V; Lue H; Kraemer S; Korbiel J; Krohn R; Ohl K; Bucala R; Weber C; Bernhagen J
FEBS Lett; 2009 Sep; 583(17):2749-57. PubMed ID: 19665027
[TBL] [Abstract][Full Text] [Related]
12. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.
Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ
J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor triggers chemotaxis of CD74+CXCR2+ NKT cells in chemically induced IFN-γ-mediated skin inflammation.
Hsieh CY; Chen CL; Lin YS; Yeh TM; Tsai TT; Hong MY; Lin CF
J Immunol; 2014 Oct; 193(7):3693-703. PubMed ID: 25172501
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor activates inflammatory responses of astrocytes through interaction with CD74 receptor.
Su Y; Wang Y; Zhou Y; Zhu Z; Zhang Q; Zhang X; Wang W; Gu X; Guo A; Wang Y
Oncotarget; 2017 Jan; 8(2):2719-2730. PubMed ID: 27926507
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor inhibits the migration of cartilage end plate-derived stem cells by reacting with CD74.
Xiong CJ; Huang B; Zhou Y; Cun YP; Liu LT; Wang J; Li CQ; Pan Y; Wang H
PLoS One; 2012; 7(8):e43984. PubMed ID: 22952837
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
Xia W; Zhang F; Xie C; Jiang M; Hou M
Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences.
Fagone P; Mazzon E; Cavalli E; Bramanti A; Petralia MC; Mangano K; Al-Abed Y; Bramati P; Nicoletti F
J Neuroimmunol; 2018 Sep; 322():46-56. PubMed ID: 29935880
[TBL] [Abstract][Full Text] [Related]
20. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion.
Liehn EA; Kanzler I; Konschalla S; Kroh A; Simsekyilmaz S; Sönmez TT; Bucala R; Bernhagen J; Weber C
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2180-6. PubMed ID: 23868943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
